The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 514.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.391%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 514.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

31 Jul 2014 07:00

RNS Number : 7902N
Creston PLC
31 July 2014
 



 

31 July 2014

 

 

Creston plc

Interim Management Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the international marketing communications group, today announces its interim management statement for the period 1 April 2014 to date.

 

In the three months to 30 June 2014 ('the Period'), there was an increase of 3 per cent in Group revenue compared to the prior year period, and like-for-like1 revenue grew by 2 per cent. This has been driven primarily by the impact of prior year client wins and the growth of our international work for existing clients.

 

Our new business performance in the first quarter of this financial year has been good with activity in line with the same prior year period and has added a breadth of new clients and digital assignments to the Group. Major wins during the Period include Activision, to handle its pan-European social media content; the growth of our events programme for Bentley from UK to pan-Europe; a new HIV prevention client at CDC; an internal referral win from Danone; McCain, to handle the digital work across all of its UK brands; the Right to Buy digital contract through the Crown Commercial Service; Sony Mobile, to manage global email production; and our first global digital win for a Unilever brand.

 

Both our recent acquisitions, healthcare PR agency Liberation and neuroscience specialist, Walnut Group, whilst not material, are performing well. Liberation was named Small Consultancy of the Year at the recent Communiqué awards for the Healthcare industry, while Walnut Group has further strengthened our Insight offering which is being increasingly leveraged across the Group as a point of differentiation to create new client opportunities.

 

The Group is on track with its previously announced plans to reposition Creston as an agency group under the unifying Unlimited brand in the second half of FY15; and effective from 1 July 2014 Kathryn Herrick joined the Board and Group as Chief Financial Officer.

 

While it is still early in the financial year, the Board confirms that current trading is in line with its expectations for the full year.

 

-ends-

 

For further information please contact:

 

Creston plc

+44 (0)20 7930 9757

Barrie Brien, Group Chief Executive

Kathryn Herrick, Chief Financial Officer

Bell Pottinger

+44 (0)20 7861 2840 

Elly Williamson / Malika Shermatova

 

___________________

1 Like-for-like excludes the results from any acquisitions made during the current year, it compares current year performance to the prior year, adjusting the current year to only include the results of prior year acquisitions for the commensurate period of ownership.

 

 

About Creston plc

Creston plc (LSE: CRE) is an international marketing communications group that leverages the strength of its agencies' collective expertise and knowledge across insight, technology and creativity to drive transformational growth for its clients through thinking and ideas that connect brands to customers. The Group delivers a range of marketing services, including advertising, CRM, digital and direct marketing, health communications, local marketing, market research, PR and social media marketing to a broad spectrum of blue-chip global clients. www.creston.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASXEDDNLEFF
Date   Source Headline
3rd May 20244:00 pmRNSNotice of Results
30th Apr 20247:00 amRNSHolding(s) in Company
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.